Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.1002/hep.29367 184 BramanteCTignanelliCJDuttaNJonesETamarizLClarkJMet al
Medical devices in obesity treatment
Participants who combined liraglutide (3.0 mg) with supervised exercise maintained at least 10% weight loss one year after stopping all treatments
IUPHAR reviewglucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Diaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG
Do not discontinue any prescribed medication without medical advice
US$ 27.02
US$ 26.97
US$ 21.34
US$ 20.60
